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Abstract: Forages are important components of dairy cattle rations but might harbor a plethora of 
mycotoxins. Ruminants are considered to be less susceptible to the adverse health effects of 
mycotoxins, mainly because the ruminal microflora degrades certain mycotoxins. Yet, impairment 
of the ruminal degradation capacity or high ruminal stability of toxins can entail that the intestinal 
epithelium is exposed to significant mycotoxin amounts. The aims of our study were to assess i) the 
mycotoxin occurrence in maize silage and ii) the cytotoxicity of relevant mycotoxins on bovine 
intestinal cells. In total, 158 maize silage samples were collected from European dairy cattle farms. 
LC-MS/MS-based analysis of 61 mycotoxins revealed the presence of emerging mycotoxins (e.g. 
emodin, culmorin, enniatin B1, enniatin B, and beauvericin) in more than 70% of samples. Among 
the regulated mycotoxins, deoxynivalenol and zearalenone were most frequently detected (67.7%). 
Overall, 87% of maize silages contained more than five mycotoxins. Using an in vitro model with 
calf small intestinal epithelial cells B, the cytotoxicity of deoxynivalenol, nivalenol, fumonisin B1 
and enniatin B was evaluated (0–200 µM). Absolute IC50 values varied in dependence of employed 
assay and were 1.2–3.6 µM, 0.8–1.0 µM, 8.6–18.3 µM, and 4.0–6.7 µM for deoxynivalenol, nivalenol, 
fumonisin B1, and enniatin B, respectively. Results highlight the potential relevance of mycotoxins 
for bovine gut health, a previously neglected target in ruminants. 
Keywords: modified mycotoxin; co-occurrence; corn silage; CIEB; WST-1; NR; SRB; sphingolipid 
metabolism; Sa/So 
Key Contribution: By analyzing 158 samples from 10 different countries, we provide a 
comprehensive overview on mycotoxin contamination patterns in European maize silages. For the 
first time, the cytotoxicity of frequently occurring Fusarium toxins was determined on bovine 
intestinal cells, resulting in a toxicity ranking of NIV > DON > ENNB > FB1.  
 
1. Introduction 
Mycotoxins are toxic secondary metabolites of different molds, such as Aspergillus spp., Fusarium 
spp., Penicillium spp. or Alternaria spp., and often found in animal feeds. They impair animal health 
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by manifold modes of action, causing hepatotoxic, nephrotoxic, immunomodulatory, genotoxic, and 
neurotoxic effects as well as reproductive and developmental disorders [1]. During the last decade, 
the intestine has moved into the spotlight of mycotoxin research. It represents the first barrier to these 
feed contaminants and is often exposed to higher mycotoxin concentrations than other body tissues. 
Here, mycotoxins do not only affect digestion and nutrient uptake, but also intestinal 
histomorphology, gut barrier integrity, mucin production, microbiota composition, and the local 
immune system [2,3]. 
Due to their frequent occurrence and negative impact on animal health, many countries have 
established regulations for mycotoxins in feed. In the European Union (EU), maximum limits are in 
place for aflatoxin B1 (AFB1) and ergot alkaloids [4], while guidance levels have been set for 
deoxynivalenol (DON), zearalenone (ZEN), ochratoxin A (OTA) and the sum of fumonisin B1 (FB1) 
and fumonsin B2 (FB2) [5]. These regulations neither take the presence of multiple mycotoxins into 
account, nor the occurrence of so-called emerging mycotoxins. This heterogenous group of fungal 
metabolites is not clearly defined, but commonly referred to as “mycotoxins, which are neither 
routinely determined, nor legislatively regulated; however, the evidence of their incidence is rapidly 
increasing” [6]. Proper risk assessment of emerging mycotoxins, e.g. enniatins, culmorins, 
beauvericin, moniliformin, roquefortine C or fusaric acid, is challenging, as data on toxicity and 
occurrence are still scarce [7].  
Forages are especially prone to contamination by emerging mycotoxins [8,9]. Fresh, dried and 
ensiled forages are important components of ruminant diets, representing 50–75% of the total diet 
[10]. Ensiling describes the preservation of green forage by lactic fermentation under anaerobic 
conditions and shows geographic variations concerning the quantity and type of silage produced 
[11]. In the EU-28 alone, approximately 2.4 million tons of green maize, which is mainly grown for 
silage, were harvested in 2018 [12]. Silages can contain a wide range of mycotoxins, that originate 
either from pre-harvest contamination, or from spoilage with (acid-tolerant and micro-aerobe) 
toxigenic fungi during storage [8]. Hence, ruminants might be exposed to a plethora of mycotoxins, 
in particular compared to chicken or swine, which have less diverse diets [9]. However, this risk has 
been poorly addressed so far, and the need for thorough mycotoxin monitoring in ruminant forages 
has been highlighted only recently [9]. 
In general, ruminants are considered to be less susceptible to mycotoxins than other livestock 
species, mainly because their ruminal microflora is capable of degrading certain mycotoxins to less 
toxic metabolites [8]. Most prominently, DON is extensively metabolized to de-epoxy-
deoxynivalenol (DOM-1), reaching conversion rates of up to 81–99% in dairy cattle [13,14]. The close 
connection between a functional ruminal microflora and DON toxicity was impressively depicted by 
Valgaeren et al. [15]. Driven by clinical cases of DON toxicosis in 2- to 3-month-old beef calves, the 
authors showed that the oral bioavailability of DON is markedly increased in non-ruminating calves 
(50.7%) compared to ruminating calves (4.1%). Moreover, it was recently demonstrated that a low 
ruminal pH-value can impair the degradation of DON, NIV, ZEN, and enniatin B (ENNB) in vitro 
[16]. Especially in the light of subacute rumen acidosis, one of the most important nutritional diseases 
in dairy cattle [17], these findings are of significant practical relevance. In addition, certain 
mycotoxins, e.g. ENNB [18], exert antimicrobial activity. It has therefore been suggested that such 
mycotoxins might alter the ruminal microflora and its degradation capacity [8]. Finally, some 
mycotoxins hardly undergo ruminal metabolism [8]. For example, limited degradation of 10–18% 
was reported for FB1 [19,20]. Hence, major amounts of mycotoxins might reach the small intestine 
and affect gut health both in non-ruminating calves and dairy cattle. 
The aims of our study were twofold. First, we investigated the mycotoxin exposure of dairy 
cattle. To this end, a total of 158 maize silage samples were collected in Europe and analyzed for 61 
mycotoxins, including regulated as well as emerging mycotoxins. Second, an in vitro model using 
calf small intestinal epithelial cells B (CIEB) was established to assess the cytotoxicity of DON, NIV, 
FB1 and ENNB. Thus, our study does not only deliver comprehensive mycotoxin occurrence data, 
but also new toxicological information regarding the relevance of mycotoxins for bovine gut health, 
a previously neglected target in ruminants.  
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2. Results 
2.1. Mycotoxin Occurrence in Maize Silage  
Maize silage samples (n = 158) were collected during a 5-year period (2014–2018) at European 
dairy cattle farms and were analyzed for mycotoxin occurrence with a liquid chromatography–
tandem mass spectrometry (LC-MS/MS)-based multi-mycotoxin method. Table 1 gives an overview 
on proportions of positive samples and detected mycotoxin concentrations in fresh silages. 
Only two out of 158 samples (1.2%) showed no mycotoxin contamination (all mycotoxins < limit 
of detection). The presence of regulated mycotoxins was absent or marginal in the case of aflatoxin 
B1 and ochratoxin A. Similarly, ergot alkaloids were only found in 2.5% of samples, with no dominant 
pattern on co-occurrence of individual alkaloids. However, since concentrations of ergot alkaloids 
were rather low, and epimerization is promoted using acidic extraction solvents, those results should 
not be over interpreted. In comparison, the Fusarium toxins ZEN and DON showed a high prevalence 
of 67.7% each. Among the regulated mycotoxins, the highest median and maximum values were 
obtained for DON with 303 µg/kg and 3,060 µg/kg, respectively. None of the samples exceeded the 
EU maximum/guidance levels set for aflatoxins, DON, FB1+FB2, ochratoxin A, or ergot alkaloids 
[4,5]. For the latter, it should be noted that the respective EU directive refers to the content of rye 
ergot (Claviceps purpurea; 1,000 mg/kg), whereas concentrations of individual ergot alkaloids were 
determined in our study. Values of the 14 ergot alkaloids were adjusted to a dry matter content of 
88% and summed up, yielding a maximum of 103 µg/kg total ergot alkaloids found in a silage sample 
from Germany. In contrast, eight samples (5.1%) contained ZEN levels ≥ 2,000 µg/kg, which 
represents the EU guidance value for cereals and cereal products, including forages. Those samples 
originated from two different countries (Austria, the Netherlands) in two consecutive years (2014, 
2015). 
Besides DON, the highest prevalence among trichothecenes was found for NIV (59.5%) and HT-
2 toxin (21.5%). Despite moderate median values, maximum NIV levels reached 5,770 µg/kg in a 
maize silage sample from Denmark (collected in 2015). Notably, another sample from the 
Netherlands contained 2,260 µg/kg NIV (2018), implying that prominent NIV levels were not limited 
to one country or season. Indicative levels for T-2+HT-2 toxin in feed were not exceeded [21]. 
Interestingly, 3-acetyldeoxynivalenol was not found in any of the samples, whereas the median value 
of 15-acetyldeoxynivaleol (274 µg/kg) was similar to the one obtained for DON.  
Furthermore, maize silages were analyzed for several modified mycotoxins, including 
deoxynivalenol-3-glucoside (DON-3-Glc), HT-2-toxin-3-glucoside (HT2–3-Glc) and nivalenol-3-
glucoside (NIV-3-Glc). Concentrations of the modified mycotoxins did not exceed the levels of the 
respective parent toxins. DON-3-Glc was found in 25.3 % of samples, albeit at low levels and with an 
average molar percentage of D3G/DON of 2.7% (0.3–9.3%). Molar percentage for HT2–3-Glc/HT-2 
toxin and NIV-3-Glc/NIV were 10.9% and 1.3% (0.9–1.6%), respectively.  
Overall, the five most frequently detected mycotoxins all belonged to the group of emerging 
mycotoxins: emodin (EMO) was found in 82.9% of samples, followed by culmorin (CUL; 79.1%), 
enniatin B1 (ENNB1; 78.5%), enniatin B (ENNB; 76.6%), and beauvericin (BEA; 76.0%). In addition, 
members of the emerging mycotoxins showed the highest median (5-hydroxyculmorin, 571 µg/kg) 
and maximum values (kojic acid 25,930 µg/kg) observed in our survey. Only six of the analyzed 
emerging mycotoxins were present in less than 10% of the samples, namely mycophenolic acid, 
enniatin B2, roquefortine C, fusaproliferin, sterigmatocystin, and enniatin B3. 
Table 1. Occurrence of tested mycotoxins in 158 dairy maize silage samples collected in Europe from 
2014 to 2018. Mycotoxin concentrations are expressed as µg/kg fresh silage. Numbers in bold indicate 




















Regulated mycotoxins (except ergot alkaloids) 3 
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Aflatoxin B1 4 0 0.0 - - - - 
Deoxynivalenol 107 67.7 303 556 1,490 3,060 
Fumonisin B1 55 34.8 60.0 147 262 553 
Fumonisin B2 46 29.1 20.4 34.4 101 133 
Ochratoxin A 4 2.5 2.38 2.51 2.62 2.65 
Zearalenone  107 67.7 15.2 61 1,110 1,670 
Ergot alkaloids 3 
Ergine 0 0.0 - - - - 
Ergocornine 0 0.0 - - - - 
Ergocorninin 0 0.0 - - - - 
Ergocristine 0 0.0 - - - - 
Ergocristinine 0 0.0 - - - - 
Ergocryptine 2 1.3 5.41 7.77 9.65 10.12 
Ergocryptinine 0 0.0 - - - - 
Ergometrine 1 0.6 49.6 49.6 49.6 49.6 
Ergometrinine 1 0.6 3.20 3.20 3.20 3.20 
Ergosin 2 1.3 1.89 1.90 1.91 1.91 
Ergosinin 0 0.0 - - - - 
Ergotamine 1 0.6 1.54 1.54 1.54 1.54 
Ergotaminine 0 0.0 - - - - 
Ergovalin 0 0.0 - - - - 
Type-A trichothecenes 
Diacetoxyscirpenol 0 0.0 - - - - 
HT-2 toxin 34 21.5 14.7 21.4 51.9 90.2 
Monoacetoxyscirpenol 4 2.5 9.91 15.9 29.5 32.9 
Neosolaniol 0 0.0 - - - - 
T-2 toxin 6 3.8 2.55 2.89 3.79 4.08 
Type-B trichothecenes 
3-Acetyldeoxynivalenol 0 0.0 - - - - 
15-Acetyldeoxynivalenol 8 5.1 274 480 624 687 




40 25.3 17.1 49.2 121 129 
HT-2-toxin-3-glucoside 5  1 0.6 6.28 6.28 6.28 6.28 
Nivalenol-3-glucoside 5 5 3.2 6.01 6.06 9.68 10.6 
α-zearalenol 12 7.6 4.84 6.93 18.1 22.2 
β-zearalenol 8 5.1 4.90 6.66 12.4 12.6 
Emerging mycotoxins 
Alternariol 45 28.5 3.11 4.45 12.1 48.1 
Alternariol methylether 37 23.4 1.95 3.46 5.79 30.8 
Apicidin 79 50.0 9.49 25.0 102 175 
Aurofusarin 108 68.4 97.8 307 3,840 4,710 
Beauvericin 120 76.0 9.16 19.0 75.9 214 
Bikaverin 42 26.6 20.3 58.8 248 415 
Butenolid 30 19.0 28.9 70.9 249 583 
Culmorin 125 79.1 190 719 2,930 6,680 
5-Hydroxyculmorin 19 12.0 571 989 1,400 1,480 
15-Hydroxyculmorin 84 53.2 229 504 1,520 1,670 
15-Hydroxyculmoron 22 13.9 204 396 441 484 
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Emodin 131 82.9 4.38 14.1 211 1,640 
Enniatin A 30 19.0 2.45 5.23 32.5 50.1 
Enniatin A1 98 62.0 2.70 8.73 25.2 173.9 
Enniatin B 121 76.6 7.07 13.8 47.4 429 
Enniatin B1 124 78.5 5.68 15.5 46.7 555 
Enniatin B2 8 5.1 3.40 5.49 16.0 20.7 
Enniatin B3 0 0.0 - - - - 
Equisetin 86 54.4 4.75 8.42 17.4 45.4 
Fusaproliferin 4 2.5 170 286 316 322.3 
Fusaric acid 35 22.2 229 998 1,800 4,120 
Kojic acid 67 42.4 96.3 185 876 25,930 
Moniliformin 71 44.9 7.84 18.5 61.6 113 
Mycophenolic Acid 9 5.7 14.8 80 262 352 
Roquefortine C 7 4.4 11.7 21.3 326 454 
Sterigmatocystin 3 1.9 2.38 5.89 8.65 9.35 
Tenuazonic acid 42 26.6 60.6 182 574 727 
1 Samples with values > limit of detection (LOD); 2 Excluding data < LOD. In case values were between 
LOD and limit of quantification (LOQ), LOQ/2 was used for calculation; 3 According to 
regulations/recommendations set by the European Commission for dairy feeds [4,5]; 4 All samples 
below < LOD for aflatoxin B2, aflatoxin G1 and aflatoxin G2; 5 Included in analysis from 2016 onwards. 
Finally, we evaluated the co-occurrence of mycotoxins in maize silages. On average, 13 
mycotoxins per sample were found (range: 0–32), and 87% of samples contained more than five 
mycotoxins (Figure 1, left). For assessment of the most frequently co-occurring mycotoxin 
combinations, toxins with an individual prevalence of ≥ 20% were considered. The most prevalent 
combinations were ENNB & ENNB1 (in 74.1% of samples), CUL & ENNB (67.7%), CUL & ENNB1 
(67.7%), CUL & DON (66.5%), and CUL & BEA (65.8%). Figure 1 (right) illustrates all mycotoxin 
combinations analyzed.  
 
Figure 1. Mycotoxin co-occurrence in maize silage samples collected at European dairy cattle farms. 
Left: Number of mycotoxins detected per sample. Right: Prevalence of different mycotoxin 
combinations (only mycotoxins with individual prevalence of ≥ 20% were used for calculations). 
2.2. Cytotoxicity of Mycotoxins on Calf Small Intestinal Epithelial Cells  
First, the species origin of used CIEB was verified via DNA Barcoding. In addition, the absence 
of mycoplasma contamination was confirmed prior to and throughout the experimental period. CIEB 
formed a cell monolayer and showed typical epithelial, cobblestone morphology (Figure 2A). For 
further characterization, immunohistochemistry was employed. Cytokeratins were expressed as a 
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network radiating from the nucleus to the plasma membrane (Figure 2B), whereas villin was 
uniformly distributed in the cytoplasma of CIEB (Figure 2C). Vimentin was strongly expressed, 
forming a filamentous network throughout the cytoplasm with increased density around the nucleus 
(Figure 2D). As expected, isotype control antibody (Mouse IgG1,) did not show a positive reaction 
(Supplementary Figure S1). 
 
Figure 2. (A) Morphology of calf small intestinal epithelial cells B (CIEB) visualized with inverse light 
microscopy (passage 10, 100 × magnification). Immunostaining of CIEB in chamber slides with (B) 
cytokeratin as an epithelial cell marker, (C) villin as marker for intestinal cells, and (D) vimentin as 
mesenchymal marker. 4′,6-Diamidin-2-phenylindol (DAPI) was used as cell nuclei counterstain (400× 
magnification). 
The cytotoxicity of DON, NIV, FB1, and ENNB on CIEB was evaluated based on metabolic 
activity (WST-1 assay), lysosomal activity (NR assay), and total protein content (SRB assay). To this 
end, cells were treated for 48 hours with increasing toxin concentrations (0–200 µM). While DON, 
NIV and FB1 were dissolved in culture medium, DMSO had to be used in case of ENNB due to its 
lower solubility. Since the DMSO proportions in the three highest ENNB concentrations (0.33–1.33% 
DMSO for 50–200 µM ENNB) affected the lysosomal activity of CIEB (Supplementary Table S1), 
respective data were excluded for calculations of IC50 values. 
All mycotoxins tested had a dose-dependent effect on metabolic and lysosomal activity as well 
as on total protein content of CIEB. Obtained absolute IC50 values varied depending on the 
mycotoxin and assay (Figure 3). Still, some general patterns were observed. First, in all assays 
employed, NIV showed the highest cytotoxicity with IC50 values ranging between 0.8 and 1.0 µM, 
followed by DON (IC50 values 1.2–3.6 µM) and ENNB (IC50 values 4.0–6.7 µM). In comparison, FB1 
showed less pronounced cytotoxic effects (IC50 values 8.6–18.3 µM). Second, the WST-1 assay 
showed the highest sensitivity for all tested mycotoxins except for ENNB. Here, the lowest IC50 value 
was obtained with the NR assay. Calculation of the absolute IC50 value for the SRB assay was not 
possible because the protein content never deceeded 50% in ENNB-treated cells.  
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Figure 3. Impact of deoxynivalenol (DON), nivalenol (NIV), fumonisin B1 (FB1), and enniatin B 
(ENNB) on metabolic activity (%) of calf small intestinal epithelial cells B assessed via the WST-1 assay 
(48 hours incubation, six independent experiments, three replicates per experiment). For comparison, 
absolute IC50 values for all three assays (WST-1, NR, SRB) are listed. 
To monitor alterations of the sphingolipid metabolism in FB1-treated cells, sphinganine (Sa) and 
sphingosine (So) were determined in cell supernatants via LC-MS/MS. Sa was significantly increased 
from 25 µM FB1 onwards, whereas no influence on So concentrations was observed (Table 2). 
Compared to the control, a significant elevation of the Sa/So ratio was evident at 6.25–200 µM FB1. 
From 12.5 µM FB1 onwards, the numerical increase of the Sa/So ratio was less distinct, indicating a 
plateau in the response. 
Table 2. Sphinganine (Sa) and sphingosine (So) concentrations as well as sphinganine to sphingosine 
ratio (Sa/So) in supernatants of calf small intestinal epithelial cells B treated with increasing 
concentrations of FB1 (0–200 µM; n = 4 independent experiments). a,b Superscripts indicate significant 
differences to cells incubated without FB1 (0 µM). 
FB1 (µM) Sa (ng/mL) So (ng/mL) Sa/So 
0 0.21 ± 0.81 a 1.40 ± 0.40 0.15 ± 0.02 a 
0.781 0.28 ± 0.10 a 1.42 ± 0.33 0.20 ± 0.03 a 
1. .563 0.53 ± 0.25 a 1.70 ± 0.47 0.31 ± 0.06 a 
3.125 3.89 ± 1.51 a 1.61 ± 0.25 2.36 ± 0.55 a 
6.25 15.60 ± 5.91 a 1.53 ± 0.25 9.98 ± 2.20 b 
12.5 33.61 ± 13.29 a 1.96 ± 0.64 16.96 ± 2.11 b 
25 44.57 ± 17.19 b 2.36 ± 1.00 19.11 ± 1.71 b 
50 50.64 ± 25.01 b 2.49 ± 1.11 20.08 ± 0.86 b 
100 53.57 ± 23.27 b 2.29 ± 0.90 23.25 ± 1.15 b 
200 56.13 ± 26.26 b 2.16 ± 0.83 25.58 ± 2.11 b 
p-value <0.0001 0.0462 <0.0001 
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3. Discussion 
Mycotoxin occurrence is influenced by multiple factors, including plant species and variety, 
region, temperature, humidity, insect damage, storage conditions, and other agricultural practices 
[22]. Our survey focused on the presence of mycotoxins in maize silage, because this feed component 
can be the main source for dietary mycotoxin intake in dairy cattle [23]. Since sample numbers per 
country and/or year were limited in our survey, definite conclusions on regional or yearly trends of 
mycotoxin occurrence were not justified and therefore omitted. Respective information can be 
retrieved from other excellent feed surveys [24] and reviews [9,11]. Similar to the approach of Storm 
et al. [25], mycotoxin concentrations were expressed as µg/kg fresh weight except for the comparison 
with EU maximum/levels, for which levels were normalized to a dry matter content of 88%. Because 
literature reports do not uniformly express mycotoxin concentrations in silage (using either fresh or 
dried weight), the suffix “fresh weight” is used in the following whenever clearly indicated in the 
respective study, or when samples were not dried prior to analysis. 
In 98.8% of silage samples at least one mycotoxin was detected. The top five positions in terms 
of prevalence were all held by emerging mycotoxins, namely EMO, CUL, ENNB1, ENNB, and BEA. 
Although data on the presence of emerging mycotoxins in feed are scarce, high incidences of 
enniatins and BEA have been described previously. For example, ENNB1, ENNB, and BEA were 
found in 97%, 90%, and 100% of maize silages collected in Poland, respectively [26]. Reported median 
values (6.0–20.9 µg/kg fresh weight) were in a similar range in our study. In silage samples from 
Spain [27], ENNB showed yearly variations in prevalence (31–72%) with higher average 
concentrations (151–163 µg/kg). In contrast, moderate incidences of around 25% for ENNB [25] and 
BEA [28] were reported in Denmark. Differences between studies might stem from distinct fungal 
contamination patterns and/or variations in methodology (e.g. sampling procedure, limits of 
detection). Reports on the toxicity of these Fusarium toxins in ruminants are completely lacking so far 
[29]. In this respect, the described antimicrobial activity of enniatins and BEA, potentially affecting 
the composition and function of the rumen microbiota, might be of special interest. In addition, 
ENNB and BEA were demonstrated to impair the barrier function in intestinal porcine enterocytes 
(IPEC-J2; [30]). Since a certain proportion of ENNB might by-pass the rumen [16], negative effects on 
the bovine gut cannot be excluded.  
To the best of our knowledge, the occurrence of EMO and CUL in European maize silages has 
not been addressed yet. In line with our data, a survey conducted in Israel showed high prevalence 
of EMO in maize silages (100%; [31]). For CUL, results deviate from our study, mostly in terms of 
incidence (6.6% versus 79.1%) but also concerning median values obtained (46 µg/kg fresh weight 
versus 190 µg/kg). This mycotoxin has recently caught scientific attention because of its potency to 
inhibit DON glucuronidation [32], and we confirmed the commonly observed co-occurrence of CUL 
and DON [7] for maize silages. Still, the relevance of CUL for dairy cattle remains debatable, as 
metabolization to DOM-1 is the primary detoxification pathway for DON in ruminants. Another 
emerging mycotoxin that has gained certain interest is fusaric acid. Shimshoni et al. [31], authors of 
the aforementioned survey in Israel, pointed out both its high prevalence and concentration in maize 
silage. Evaluated on a larger sample size and in a different region, our findings corroborate a certain 
relevance for fusaric acid (detected in nearly one quarter of silages, maximum concentration of 4,120 
µg/kg fresh weight). Concerns for bovine health were related to the growth inhibition of important 
rumen microorganisms and the toxin’s potential carry over to milk [31]. However, like for other 
emerging mycotoxins, toxicodynamic and toxicokinetic studies are warranted to verify these 
assumptions and to elucidate the role of fusaric acid for food safety.  
FB1+FB2 were detected in approximately one third of the samples, albeit at low concentrations. 
As unveiled by Latorre et al. [33], the majority of fumonisins in maize silage are present in a modified 
form. These so-called “hidden fumonisins” escape routine analysis, but are expected to be released 
upon mammalian digestion [34]. For assessing the total fumonisin burden, alkaline hydrolysis of 
samples is required [33]. This was not performed in the present case and thus represents a limitation 
of our study. Similarly, total exposure to type-A or -B trichothecenes is underestimated in surveys 
that do not account for acetylated or modified forms. In our study, DON showed a high prevalence 
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of 67.7% with moderate median concentrations of 303 µg/kg fresh weight. In the past, higher average 
DON values of 1,629 µg/kg fresh weight [25] or 854–1,316 µg/kg [10,27] were monitored, and 
incidences varied substantially from 6.1–86% [25–27,35]. While average molar DON-3-Glc/DON 
percentages of 20% were proposed for cereals [36], we found markedly lower values of 2.72%. Further 
studies are necessary to assess whether this observation is related to the commodity maize silage as 
such or merely to our sample set. The same applies to our findings on NIV-3-Glc and HT2–3-Glc, 
both showing negligible prevalence. Although this indicates that NIV-3-Glc does not contribute 
significantly to the total NIV burden of dairy cattle, the prominent prevalence of the parent toxin 
(59.5%) must be underlined. Maximum NIV values exceeded previously reported data [25,26,37], 
revealing that the NIV exposure can be extremely high for individual dairy cattle herds.  
ZEN was the only mycotoxin found at levels above the EU maximum/guidance limits [4,5], with 
5.1% of samples exceeding ≥ 2,000 µg/kg ZEN. In most mycotoxin surveys, maize silages complied 
to the EU regulations [10,25,26,37], whereas Dangac et al. [27] reported 1.4% of samples exceeding 
the recommended maximum levels for ZEN. It should be noted that a different limit was employed 
in that study (500 µg/kg ZEN for complete feedstuffs), which hampers a direct comparison of results. 
Still, data emphasize the need to monitor ZEN in maize silage and to control its formation pre- and 
postharvest. This is especially important in the light of potential synergistic effects with other 
mycotoxins. Naturally, ZEN often co-occurred with DON (63.3%). While exposure to diets co-
contaminated with ZEN and DON did not affect the performance of dairy cows [38], alterations of 
health-related blood parameters were observed by Dänicke et al. [39]. In addition, authors suggested 
an influence on ketogenesis at the cellular level. Clearly, more studies are needed to decipher the 
interactions of DON and ZEN in ruminants. The same is valid for other mycotoxin combinations. 
Co-occurrence of mycotoxins might be of relevance for animal health even at comparably low 
concentrations. As summarized by Chehli et al. [40], the type and intensity of mycotoxin interactions 
can vary dose-dependently. Our study confirmed that mycotoxin co-occurrence in feed is rather the 
rule than the exception. Strikingly, silage samples contained 13 mycotoxins on average, and in 87% 
of samples more than five mycotoxins were found. These high values are partly attributed to the 
broad palette of mycotoxins tested in our study, and therefore, further expand existing knowledge 
on mycotoxin co-contamination in maize silage (e.g. Refs. [9,26,27]).  
Next, we investigated the impact of silage mycotoxins on bovine gut health. Based on our survey 
results, we focused on Fusarium toxins and assessed the cytotoxic potential of DON, NIV, FB1, and 
ENNB on bovine intestinal cells. Toxins were selected due to their high prevalence (DON, ENNB), 
maximum concentrations (NIV) or ruminal stability even under physiological conditions (FB1; [20]). 
The toxicity of mycotoxins in bovine intestinal cells is currently unknown, mainly because of two 
reasons. First, the rumen microbiota was long thought to neutralize the toxicity of mycotoxins. 
However, recent studies indicate that the ruminal degradation capacity might be impaired under 
specific conditions, such as altered ruminal development in calves [15] or rumen acidosis [16]. 
Second, the small number of commercially available bovine lines restrains research in this field. 
Since CIEB are not widely used, we first confirmed the species identity and the absence of 
mycoplasma contamination. Although these aspects are of paramount importance for reliable and 
reproducible in vitro results, they are often neglected. Mycoplasma contamination can alter the 
properties of cell lines, and infected CIEB were described to exhibit low viability and poor growth 
[41]. In the same study, authors reported misidentification of three out of eight tested cell lines. The 
dimension of this issue is even more striking when retrieving information from the International Cell 
Line Authentication Committee, which has documented 451 false identified cell lines [42]. Resources 
wasted in the last 50 years due to misidentification of cell lines, stemming from cross-contamination, 
wrongly labelled samples or inadequate protocols, can only be estimated [43]. Consequently, 
increased attention should be paid to adequate quality controls for in vitro experiments, also in 
mycotoxin research. 
Further characterization of CIEB was performed by immunofluorescence staining. CIEB showed 
a positive reaction for cytokeratins and villin. Cytokeratin proteins, which are characteristic 
components of the cytoskeleton, are commonly used for identification of epithelial cells [44]. Villin is 
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an actin-binding protein in the microvilli of epithelial cell [45]. Expression of both proteins has been 
used to verify the intestinal epithelial nature of bovine cells before [46]. Besides, CIEB were immuno-
positive for vimentin. This protein is a typical marker for non-epithelial cells, such as fibroblasts [47]. 
However, unequivocal identification of fibroblasts remains challenging. For example, the expression 
of vimentin was reported for the intestinal porcine epithelial cell line (IPEC-J2; [48]). Another study 
even excluded the presence of fibroblasts in cells isolated from calf intestine although they showed a 
positive reaction for vimentin [49]. It seems that the expression of vimentin is not a unique property 
of mesenchymal cells but can also be found in intestinal epithelial cells and should be evaluated in 
combination with the presence/absence of cytokeratin expression. Altogether, our 
immunohistochemistry results asserted the epithelial intestinal origin of CIEBs. 
Absolute IC50 values of mycotoxins were calculated based on viability tests performed with 
three different assays (WST-1, SRB, NR). Independent of the assay, NIV was the most cytotoxic 
mycotoxin (IC50 0.8–1.0 µM), closely followed by DON (1.2–3.6 µM). The higher comparative 
cytotoxicity of NIV is in accordance to experiments performed in human (epithelial colorectal 
adenocarcinoma cells, Caco-2; [50]) and porcine intestinal cells (IPEC-1, IPEC-J2; [51,52]). Likewise, 
the absolute IC50 values obtained for NIV and DON in CIEB are in a similar range as reported 
previously. For example, IC50 values for NIV were 0.9–2.1 µM in Caco-2, IPEC-1 and IPEC-J2 cells 
[50–52], and 0.9–3.6 for DON [50–53]. Opposed to that, individual studies found higher IC50 values, 
e.g. 6.9 µM for NIV [54] or up to 44.8 µM for DON [55]. Differences between studies can derive from 
experimental conditions, such as cultivation medium, tested concentration range, exposure period, 
chosen endpoint, calculation of IC50 values, or differentiation status of cells [40]. Overall, data 
indicate that CIEB are at least as sensitive to NIV and DON as human or porcine intestinal cells. 
For ENNB, a higher cytotoxicity compared to NIV [54] and DON [56] was observed in Caco-2, 
which could not be confirmed for CIEB. Interestingly, the most sensitive IC50 value for ENNB (4.0 
µM) was generated by the NR assay, which measures lysosomal activity. Indeed, destabilization of 
lysosomes has been suggested as an upstream event of ENNB-induced cell death [57]. As IC50 values 
after incubation periods of up to 48 hours varied strongly in Caco-2 (2.1 to > 30 µM; [18]), comparison 
of results is challenging. Still, in line with the present study, it was reported that the NR assay yields 
lower IC50 values for ENNB than assays measuring metabolic activity [57,58]. Since mitochondria 
are one of the major cellular targets of enniatins [18], we originally assumed a strong response in the 
WST-1 assay. However, among other effects on these cell organelles, enniatins induced swelling of 
rat liver mitochondria [59]. Interestingly, the same phenomenon was described for IPEC-J2 cells 
exposed to DON, and here the comparably weaker cytotoxic response assessed by the WST-1 assay 
was partly attributed to alterations of the mitochondrial morphology and metabolic activity [30]. 
Although further mechanistic studies are needed, cumulative data suggest that the metabolic activity 
does not represent the most sensitive endpoint for cytotoxicity assessment of ENNB. For the SRB 
assay, calculation of an IC50 value was not possible. To the best of our knowledge, no other study 
has employed this test to determine the cytotoxicity of ENNB so far. Hence, we cannot conclude 
whether the total protein content is the least sensitive endpoint for this mycotoxin or whether this 
finding is rather limited to our experimental conditions. Concordant with Springler et al. [55], our 
study underlines the importance of multi-parameter analysis in the cytotoxicity assessment of 
mycotoxins.  
FB1 showed the lowest cytotoxicity among the toxins tested in our study. Considering previous 
studies demonstrating minor cytotoxicity of this mycotoxin in Caco-2 [60–63] and IPEC-J2 [52,64], 
these results are not surprising. Still, it should be noted that IC50 values obtained in CIEB are 
markedly lower than the ones reported previously for other intestinal cells (if computable at all). This 
might be partly related to the narrow concentration range tested in some of the studies [52,60,63]. 
FB1-induced effects on the intestine were proposed to originate from disruption of the sphingolipid 
metabolism which causes intracellular accumulation of the sphingoid bases sphinganine (Sa) and 
sphingosine (So) [65]. In line with reports addressing intestinal tissues/cells from monogastric 
livestock species [66,67], a dose-dependent increase of the Sa/So ratio was observed in CIEB. 
Compared to Loiseau et al. [66], who found a significant elevation of the Sa/So ratio after 48 hours of 
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exposure to 100 µM FB1 in IPEC-J2, CIEB reacted to lower toxin concentrations, reaching statistical 
significance at 6.25 µM FB1. Yet, absolute Sa/So values were smaller in our study, which might be 
explained by the type of matrix used for analysis (cell extract [66] or supernatant).  
Although ZEN showed high prevalence in silage samples and was the only mycotoxin exceeding 
the EU guidance levels, we did not include this compound in our cytotoxicity experiments. This 
decision was mainly based on the primary mode of action of ZEN, which is the activation of estrogen 
receptors [68]. Compared to other mycotoxins, the effects of ZEN on the intestine are less detrimental 
[69]. For example, IC50 values for ZEN obtained by measuring metabolic activity in Caco-2 were 
313 µM [70] and 25 µM [62] after 48 and 72 h of incubation, respectively, and thus even higher than 
those observed for FB1 in the same experiments. However, increased sensitivity of CIEB to ZEN 
cannot be ruled out at this stage and should be addressed in future studies. In vitro models represent 
an essential tool to unravel the toxicological relevance and mode of action of substances. Yet, direct 
extrapolation to in vivo conditions is often limited, mainly because in-vitro experiments cannot fully 
reflect the complexity of an intact organism [40]. In an attempt to compare concentrations used in our 
in vitro experiment to mycotoxin levels in dairy feed, we used the dataset provided by Seeling et al. 
[14]. In this study, 14 duodenal fistulated cows were exposed to DON-contaminated feed, which 
allowed the assessment of the toxin’s duodenal flow. On average, 1.3% on ingested DON reached the 
duodenum in unmetabolized form. This low proportion partly stemmed from ruminal absorption of 
the toxin, but mostly from metabolization to DOM-1 (94–99%). Calculating with this percentage, the 
IC50 value for DON in CIEB (356 µg/L; WST-1) theoretically corresponds to a feed concentration of 
approximately 27,400 µg/kg. Although this value exceeds the maximum DON levels detected in fresh 
maize silage by a factor of ten, it should not be overlooked that minor changes in the ruminal 
degradation capacity would have a marked impact on the outcome of this estimation. As such, it 
highlights the practical relevance of our findings.  
4. Conclusions 
Our survey reports a high prevalence of emerging mycotoxins, namely EMO, CUL, enniatins 
and BEA, in European maize silages. In addition, the well-known Fusarium toxins ZEN, DON and 
NIV were frequently detected, often co-occurring with the listed emerging mycotoxins. Based on the 
comparison of obtained IC50 values, our data indicate that CIEB are at least as sensitive to NIV, DON, 
ENNB and FB1 as human or porcine intestinal cells. Thus, our study stresses the potential negative 
health impact of mycotoxins on bovine gut health and highlights the need for further research in this 
field. In particular, effects of mycotoxin combinations on the composition and functionality of the 
rumen microbiota as well as on bovine gut health in vivo should be addressed  
5. Materials and Methods  
5.1. Mycotoxin Survey  
In total, 158 maize silage samples were collected at European dairy cattle farms from January 
2014 to December 2018. Per year, 19 (2014), 20 (2015), 51 (2016), 36 (2017), and 31 (2018) samples were 
taken. The 10 countries of origin are displayed in Figure 4. 
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Figure 4. Number of maize silage samples per country of origin. 
Samples were provided by the BIOMIN Mycotoxin Survey Program and collected as described 
previously [71]. Feed was sent for analysis in paper bags or bags with ventilation to avoid humidity 
building up. Prior to LC-MS/MS analysis, aliquots of 500 g were dried (60 °C, 48 h; drying cabinet FP 
24, Binder GmbH, Tuttlingen, Germany), and the dry matter content was determined simultaneously. 
Thereafter, dried samples were homogenized, extracted and subjected to LC-MS/MS-based multi-
mycotoxin analysis according to Malachovà et al. [72]. Details regarding the identification and 
quantification of mycotoxins as well as the method performance are reported in the aforementioned 
publication. The accuracy of the method is verified by regular participation in proficiency testing 
schemes including samples of complex animal feed [72,73].  
Final mycotoxin concentrations were corrected for dry matter content and expressed as µg/kg 
fresh weight (average dry matter content 36.5 ± 8.6%). Samples with mycotoxin levels below the limit 
of detection (LOD) were considered negative. In case samples shown a mycotoxin concentration 
between the LOD and limit of quantification (LOQ), LOQ/2 was used to calculate median and 
percentile values. For evaluation of samples exceeding the EU legislation on 
maximum/guidance/indicative mycotoxin levels in feed [4,5,21], values were normalized to a dry 
matter content of 88%. Specifically, the guidance values for the category “Feed materials – Cereals 
and cereal products” were used for DON (8,000 µg/kg), ZEN (2,000 µg/kg) and ochratoxin A (250 
µg/kg). In the case of FB1, the guidance level for “Feed materials – Maize and maize products” was 
selected (60,000 µg/kg), whereas for the sum of T-2 and HT-2 toxins, the indicative level for “Cereal 
products for feed and compound feed – Other cereal products” (500 µg/kg) was used.  
5.2. In vitro Experiments  
5.1.1. Cell Line  
Calf small intestinal epithelial cells B (CIEB) are a spontaneously immortalized cell line from bos 
taurus (NCBI Taxonomy: 9913). CIEB clone 9 (RRID:CVCL_6A77) were originally purchased from 
Bionutritec (Iunel, France). 
Prior to the conduction of experiments, cells were checked for the absence of mycoplasma 
contamination with the broth-agar microbiological culture method (Friis and PH broth and agar 
media; German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany). In 
addition, CIEB were sent to DSMZ for confirmation of species identification. Cells were tested to be 
free of mitochondrial DNA sequences from human (detection limit: 10–3) as well as from mouse, rat, 
and Syrian and Chinese hamster (detection limit:10–5). DNA Barcoding by PCR amplification of the 
5´-coding region of Cytochrome C Oxidase I and sequencing of the respective PCR product was used 
to confirm the species origin of CIEB.  
5.1.2. Routine Cultivation of CIEB 
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Cells were maintained in high glucose (4.5 g/L) Gibco® D-MEM medium (Invitrogen, Thermo 
Scientific, Vienna, Austria). Media was supplemented with 10% fetal bovine serum (Life 
Technologies, Thermo Scientific, Vienna, Austria), 16 mM HEPES (Sigma Aldrich, Vienna, Austria), 
Gibco® 2.5 mM GlutaMAX™, and penicillin/streptomycin (100 units/mL; 100 µg/mL; Sigma 
Aldrich)). CIEB were cultivated at 37 °C in a 5% CO2 atmosphere (Galaxy 48 S, New Brunswick, 
Eppendorf, Hamburg, Austria). At first passage, coated (Coating Matrix Kit, Life Technologies) 25-
flasks (Star Lab, Hamburg, Germany) were used. Thereafter, cells were cultivated in uncoated 75-
flasks (Star Lab). CIEB were subcultured two to three times a week upon reaching 80% confluence. 
Cells were used until passage 24 and regularly confirmed to be free of mycoplasma contamination 
via PCR (Venor® GeM Mycoplasma Detection Kit; Minerva Biolabs, Berlin, Germany). 
5.1.3. Characterization of CIEB by Immunohistochemistry (Cytokeration, Vimentin and Villin) 
For antibody staining, eight well cell imaging slides (Eppendorf, Hamburg, Germany) were 
coated with a Coating Matrix Kit (Life Technologies). CIEB were seeded at a density of 2 × 104 
cells/well and incubated for 48 hours at 37 °C and 5% CO2. Cells were washed twice with PBS before 
fixing them with 4% paraformaldehyde solution for 10 minutes at 4 °C. Subsequently, cells were 
washed again with PBS. For permeabilization, cells were incubated with PBS containing 0.1% Triton 
X-100 at 200 rpm followed by another washing step with PBS. Blocking was performed by incubating 
cells for 1 hour at 200 rpm with a 2% BSA solution at room temperature, followed by a washing step 
with PBS. Thereafter, cells were incubated with primary antibodies for 1 hour at room temperature: 
mouse anti-pan cytokeratin antibody [C11] (1:250 dilution, ab7753, Abcam), mouse anti-vimentin 
antibody [RV202] (1:150, dilution, ab8978, Abcam), mouse anti-villin antibody [3E5G11] - N-terminal 
(1:250 dilution, ab201989, Abcam). Mouse IgG1, Kappa Monoclonal [B11/6]–Isotype Control (1:250 
dilution, ab91353, Abcam) was used as isotype control. After another washing step, cells were 
incubated for 2 hours at room temperature in the dark with the secondary antibody: goat anti-mouse 
IgG H&L FITC (1:2,000, ab6785, Abcam). Thereafter, cells were washed again, and three drops/well 
of a fluoroshield mounting medium containing DAPI (Abcam) were added for 5 minutes at room 
temperature in the dark. Finally, the chambers of the imaging slides were removed, and cover glasses 
were added.  
5.1.4. Cytotoxicity Tests 
Solid mycotoxin standards were purchased from Romer Labs (Tulln, Austria; DON, NIV and 
FB1) or Sigma Aldrich (ENNB). For the preparation of stock solutions, 5 mg of DON, NIV and FB1 
were dissolved in appropriate amounts of culture medium to yield a concentration of 1 mM, 
respectively. In the case of ENNB, 5 mg of the standard were dissolved in DMSO to achieve a 
concentration of 15 mM. All stock solutions were stored at −20 °C.  
CIEB were seeded in 96-well plates (Eppendorf, Vienna, Austria) with a density of 2 × 104 
cells/well and 200 µL medium/well. After 24 hours, cells were incubated with DON, NIV, FB1 (0–200 
µM) or ENNB (0–200 µM; DMSO 0–1.33%) in triplicate for 48 hours. Thereafter, three different assays 
were performed to assess the cytotoxicity of increasing mycotoxin concentrations. First, the water-
soluble tetrazolium (WST-1; Roche, Rotkreuz, Switzerland) was performed to assess the metabolic 
activity of CIEB. While the sulforhodamine B assay (SRB; Xenometrix, Allschwil, Switzerland/Sigma 
Aldrich) was used to measure the total protein synthesis of cells, the neutral red assay (NR, 
Xenometrix) was used the measure the ability of viable cells to incorporate and bind neutral red 
within lysosomes. All tests were performed according to the instructions of the manufacturer. Six 
independent experiments were performed for each mycotoxin and test, respectively.  
5.1.5. Sphinganine and Sphingosine Analysis  
In supernatants of FB1-treated cells, the concentration of the sphingoid bases sphinganine (Sa) 
and sphingosine (So) were determined via LC-MS/MS as described in Reisinger et al. [74]. 
Supernatants from triplicates were pooled, and four independent experiments were performed. 
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5.1.6. Data Analysis  
Statistical analysis was performed with GraphPad Prism (Prism version 8 for Windows, 
GraphPad Software, La Jolla, California, USA). Absolute IC50 values of data from the WST-1, NR and 
SRB assays were calculated with relative numbers. After data normalization, a four-parameter 
nonlinear regression curve [log (inhibition) versus response with variable slope (least squares 
ordinary fit, with the condition that the Hillslope is < 0)] was applied to calculate the IC50 values. 
Sa/So ratios were calculated by dividing the Sa concentration by the So concentration of each 
experiment. As data were not normally distributed, the Kruskal-Wallis test was performed as a non-
parametric test. Dunnett’s test was used as a post-hoc test to compare different FB1 concentrations 
against cell control (0 µM FB1). 
For the extrapolation of DON concentrations used in vitro to DON levels in feed, data from 
Seeling et al. [14] were used. Average DON recovery in duodenum (% of ingested DON) was 
calculated based on the individual data provided for 14 cows in table 3 of the publication. 
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Immunostaining of calf small intestinal cells B (CIEB) in chamber slides with isotype control antibody for 
cytokeratin, villin and vimentin, Table S1: Impact of the solvent DMSO (0–10%) on metabolic activity (%) of calf 
small intestinal epithelial cells B assessed via the WST-1, NR, and SRB assay (48 hours incubation, four 
independent experiments, three replicates per experiment). 
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